Etravirine Tablet
Product Images NDC 69452-254

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etravirine (NDC 69452-254). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image01 (Imag01)

Label for Etravirine Tablets, USP 100 mg oral tablets by Bionpharma Inc. The label includes dosage, storage instructions, an alert about medicine interactions, quantity of 120 tablets, and barcodes. It specifies prescription use and provides distributor contact details.*

FDA Label Image

Image02 (Image02)

Label for Etravirine Tablets USP 200 mg oral tablets by Bionpharma Inc. The label states the strength (200 mg), package quantity (60 tablets), and storage instructions. It includes a warning about medicines that should not be taken with etravirine and notes the product is made in India. The label also features batch and distribution details, a barcode, and temperature storage guidance.*

FDA Label Image

Chemical Structure (Structure01)

Chemical structure of etravirine, depicted as a molecular diagram showing the arrangement of atoms and bonds characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.